Volume 207, Issue suppl_2, June 2013

The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings

• Extract
• View article

Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings

• Abstract
• View article

Transmission of Drug Resistant HIV and Its Potential Impact on Mortality and Treatment Outcomes in Resource-Limited Settings

• Abstract
• View article
• Supplementary data

Antiretroviral Treatment Sequencing Strategies to Overcome HIV Type 1 Drug Resistance in Adolescents and Adults in Low-Middle-Income Countries

• Abstract
• View article

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine

• Abstract
• View article
• Supplementary data

Resistance at Virological Failure Using Boosted Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors As First-Line Antiretroviral Therapy—Implications for Sustained Efficacy of ART in Resource-Limited Settings

• Abstract
• View article
• Supplementary data

Development of Antiretroviral Resistance in Children With HIV in Low- and Middle-Income Countries

• Abstract
• View article

Impact of Antiretroviral Drugs in Pregnant Women and Their Children in Africa: HIV Resistance and Treatment Outcomes

• Abstract
• View article

Oral Antiretroviral Drugs as Public Health Tools for HIV Prevention: Global Implications for Adherence, Drug Resistance, and the Success of HIV Treatment Programs

• Abstract
• View article

Cover

• View article

Title page

• View article

Table of Contents

• View article